Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell turnours [PDF]
, 2007 Background: Sertoli-Leyclig cell tumours of the ovary account for only 0.2% of malignant ovarian tumours. Two-thirds of all patients become apparent due to the tumour's hormone production. Methods: A 41-year-old patient (gravida 4, para 4) presented with
Campisi P +12 more
core +2 more sources
Diagnostic value of qualitative and strain ratio elastography in the differential diagnosis of non-palpable testicular lesions [PDF]
, 2016 The purpose of this study was to evaluate prospectively the accuracy of qualitative and strain ratio elastography (SE) in the differential diagnosis of non-palpable testicular lesions.
BARBAGALLO, FEDERICA +12 more
core +1 more source
Leydig Cell Tumor in Children: a Case Report and Literature Review
Translational Research in Urology, 2020 Introduction Leydig cell tumors (LCTs) comprising of 1 to 3 percent of testicular cancers in children, one of the single most common symptoms in prepubertal patients is painless testicular swelling with or without a sign of precocious puberty.
Khashayar Atqiaee +3 more
doaj +1 more source
Effects of heme oxygenase isozymes on Leydig cells steroidogenesis [PDF]
, 2009 In the present study, we demonstrate the expression of heme oxygenase (HO) isozymes, HO-1 and HO-2 (listed as HMOX1 and HMOX2 in the MGI Database), in MA-10 Leydig tumor cells and its effect on steroidogenesis. The well-known HO inducer, hemin, increased
Besio Moreno, Marcos Alberto +6 more
core +1 more source
Laporan Kasus Leydig Cell Tumor
Indonesian Journal of Cancer, 2008 Leydig cell tumor (LCT) merupakan neoplasma testis yang jarang. Tumor ini meliputi 1-3% dari 2,5 kasus insidens tumor testis per 100.000 orang/tahun. Leydig cell tumor dapat terjadi pada orang dewasa dengan 10% di antaranya berpotensi maligna dan pada ...
Egi Edward Manuputty +2 more
doaj +1 more source
Synchronous Leydig Cell Tumor and Seminoma in the Ipsilateral Testis
Case Reports in Urology, 2018 Leydig cell tumor is a rare sex cord tumor that accounts for 1–3% of all testicular neoplasms. Seminomas are more common and occur in 30–40% of testicular tumors.
Ifeyinwa E. Obiorah +2 more
doaj +1 more source
TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria [PDF]
, 2016 The 18-kDa translocator protein (TSPO) localizes in the outer mitochondrial membrane (OMM) of cells and is readily up-regulated under various pathological conditions such as cancer, inflammation, mechanical lesions and neurological diseases. Able to bind
Aghazadeh +189 more
core +1 more source
Oncologic outcomes following surgical management of clinical stage II sex cord stromal tumors [PDF]
, 2019 Objective To investigate the clinical history of patients with clinical stage II sex cord stromal tumors who underwent RPLND at our institution. Methods Our prospectively maintained testicular cancer database was queried to identify patients who ...
Calaway, Adam C. +3 more
core +1 more source
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases [PDF]
, 2017 BACKGROUND: Cytotoxic therapy for relapsed and refractory germ cell tumors or metastatic sex cord stromal tumors is rarely effective and is often accompanied by high adverse event rates.
Albany, Costantine +5 more
core +1 more source
Rare Tumors, 2017 Sertoli-Leydig cells tumors are rare ovarian neoplasms that can be managed with conservative resection given their generally excellent prognosis.
Jonathan E. Zuckerman, Neda A. Moatamed
doaj +1 more source